U.S. Rep. Gallagher: Introduces legislation to ensure transparency in prescription drug pricing

Contact: Jordan Dunn


WASHINGTON, D.C.
 – Congressman Mike Gallagher (R-WI) yesterday introduced HR 3805, the Prescription Drug Rebate Reform Act of 2019. This bill would bring transparency to drug pricing and help lower out-of-pocket prescription drug costs by requiring all patients’ coinsurance obligations to be set as a percentage of net price, rather than list price, before or after a deductible is met. Senators Mitt Romney (R-UT) and Mike Braun (R-IN) introduced companion in the legislation in the U.S. Senate. A summary of the legislation is available here.

“Skyrocketing prescription drug prices have placed an incredible burden on families in Northeast Wisconsin and across the country,” said Rep. Gallagher. “At a time when complexities in our healthcare system have allowed insurance companies and drug manufacturers to raise the cost of prescription drugs at the patient’s expense, it’s clear that Congress needs to increase transparency and change cost-sharing rules. This legislation takes an important step forward in achieving those goals.”

SHARE